Dicyandiamide – 70 Years of Sustainable Competence and Responsibility
Dicyandiamide – 70 Years of Sustainable Competence and Responsibility

Dicyandiamide

In 1950, SKW Trostberg, as the forerunner to AlzChem, started production of Dicyandimide (DCD). The production plant has been in continuous operation ever since, and constantly improved so that in the current day it respresents one of the most efficient, technically advanced and pollution-free DCD processes in the world. Furthermore, with a capacity of 20,000 to per annum it still represents one of the largest DCD facilities worldwide, and one of the only remaining DCD facilities located outside of China. It fills us with pride that in 2016 we exceeded the total production volume of 1,000,000 tons of DCD.

The big advantage of DCD is that it is extremely reactive but nevertheless non-hazardous, and because of this it is used in a wide variety of applications. The largest application field is as a synthetic component for the production of active pharmaceutical ingredients (API’s), inter alia for the manufacture of the type II anti-diabetes drug Metformin. Another major application field is the hot-curing of epoxy resins for industrial applications, and in recent years Dicyandiamide has a growing importance as a nitrogen stabiliser for agicultural fertilisers. Internally Alzchem also use DCD as a raw material in forward-integrated intermediate products for the production of a diverse range of guanadine salts, guanamines and DCD based condensation products; used in air bags, water treatment, flame retardants, textiles, leather tanning and finishing, and pulp and paper finishing auxiliaries.

Dr. Ralf Oeschey

Dr. Ralf Oeschey

T +49 8621 86-2508

ralf.oeschey@alzchem.com

News

Over the years AlzChem has built-up a wealth of expertise in micronizing products. We can now draw upon our experience of more than 20 years in this field. We can mix, micronize and homogeneously fill different substances in our in-house milling center at the AlzChem production site Schalchen in Germany. We proudly offer excellent process implementation and support based on many years of expertise, application technology skills and our own research department. AlzChem offers customer...
read more
For many years, AlzChem has been supporting its pharma customers with a wide range of intermediates for medicinal products such as treatment of HIV, cancer, hypertension and diabetes. The current COVID-19 health crisis has again demonstrated the emerging problem of shortages of medicines in Europe and led to consideration of the European Union to regain its health sovereignty by decreasing dependence on non European countries.  Currently, our customers appreciate the reliable...
read more
As a supplier of raw materials for the pharmaceutical industry, AlzChem is now also helping to produce “corona tests”: intermediate products from AlzChem are used in both tests that detect SARS-CoV-2 and the tests used to detect antibodies.   For many years AlzChem has been reliably supplying various pharmaceutical companies with the two intermediate products guanidine hydrochloride and guanidine thiocyanate. Both are now also used to manufacture the corona tests that are currently...
read more
Many years of extensive experience in complex organic chemistry - including moisture-free and oxygen-free organometallic reactions as well as large-scale Grignard reactions in diethyl ether - are among the traditional core competencies of AlzChem. Thanks to the extensive knowledge of the experts on the reactivity of cyanamide, the company was able to establish numerous intermediates for medications based on NCN chemistry on a commercial scale in its multipurpose facilities, including cancer...
read more